Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
methotrexate (ADX-2191)
i
Other names:
ADX-2191
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Aldeyra
Drug class:
THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor
Related drugs:
‹
pemetrexed (58)
methotrexate (37)
pralatrexate (2)
pemetrexed RTD (1)
LX-101 (0)
pemetrexed (0)
methotrexate oral solution (0)
methotrexate IV (0)
pemetrexed (58)
methotrexate (37)
pralatrexate (2)
pemetrexed RTD (1)
LX-101 (0)
pemetrexed (0)
methotrexate oral solution (0)
methotrexate IV (0)
›
Associations
News
Trials
Filter by
Latest
23d
A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma (clinicaltrials.gov)
P3, N=20, Recruiting, Aldeyra Therapeutics, Inc.
23 days ago
New P3 trial
|
methotrexate (ADX-2191)
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.